dihydrotestosterone has been researched along with Urinary Retention in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, KE; Santti, R; Streng, TK; Talo, A | 1 |
| Marks, LS | 1 |
| Ray, P; Roehrborn, CG | 1 |
1 review(s) available for dihydrotestosterone and Urinary Retention
| Article | Year |
|---|---|
Use of 5alpha-reductase inhibitors to prevent benign prostatic hyperplasia disease.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgens; Biomarkers; Dihydrotestosterone; Disease Progression; Enzyme Inhibitors; Humans; Male; Prostate-Specific Antigen; Prostatic Hyperplasia; Quality of Life; United States; Urinary Retention | 2006 |
1 trial(s) available for dihydrotestosterone and Urinary Retention
| Article | Year |
|---|---|
Efficacy and tolerability of the dual 5alpha-reductase inhibitor, dutasteride, in the treatment of benign prostatic hyperplasia in African-American men.
Topics: 5-alpha Reductase Inhibitors; Acute Disease; Aged; Aged, 80 and over; Azasteroids; Biomarkers; Black or African American; Dihydrotestosterone; Double-Blind Method; Dutasteride; Enzyme Inhibitors; Humans; Linear Models; Male; Middle Aged; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Hyperplasia; Severity of Illness Index; Testosterone; Treatment Outcome; Urinary Retention; Urination; Urodynamics; Urologic Surgical Procedures, Male; White People | 2006 |
1 other study(ies) available for dihydrotestosterone and Urinary Retention
| Article | Year |
|---|---|
A dose-dependent dual effect of oestrogen on voiding in the male mouse?
Topics: Animals; Dihydrotestosterone; Dose-Response Relationship, Drug; Estradiol; Estrone; Male; Mice; Mice, Inbred C57BL; Muscle Contraction; Orchiectomy; Urinary Bladder; Urinary Retention | 2005 |